Predicting Microvascular Invasion in Liver Transplant Recipients for Hepatocellular Carcinoma
Author Information
Author(s): Muacevic Alexander, Adler John R, Aujla Usman I, Syed Imran Ali, Rafi Kashif, Naveed Ammara, Malik Ahmad K, Khan Muhammad Yasir, Haq Ihsan Ul, Rashid Sohail, Butt Osama T, Dar Faisal
Primary Institution: Pakistan Kidney and Liver Institute and Research Center, Lahore, PAK
Hypothesis
The study assessed the pre-transplant factors to predict microvascular invasion (MVI) on explant liver specimens.
Conclusion
The study highlights the clinical significance of pre-operative alpha-fetoprotein levels as a predictor of microvascular invasion in patients with hepatocellular carcinoma undergoing liver transplantation.
Supporting Evidence
- 26% of liver transplant recipients were diagnosed with hepatocellular carcinoma.
- Pre-operative alpha-fetoprotein levels were significantly associated with microvascular invasion.
- Microvascular invasion was present in 28.7% of explant specimens.
- Logistic regression showed pre-operative alpha-fetoprotein as the only independent predictor of microvascular invasion.
Takeaway
Doctors can use a blood test for alpha-fetoprotein to help predict if liver cancer will spread in patients before they get a liver transplant.
Methodology
This retrospective study included adult liver transplant recipients with hepatocellular carcinoma to identify pre-transplant predictors of microvascular invasion using univariate and multivariate analyses.
Limitations
The study had a shorter follow-up period which might not capture higher recurrence rates.
Participant Demographics
The mean age of participants was 54.06 years, with a majority being male (76.47%) and hepatitis C as the leading cause of liver disease (72.8%).
Statistical Information
P-Value
0.001
Confidence Interval
1.003-1.008
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website